Palivizumab 100MG/m 1S
Ended Awarded
- Contract number
- SPE2DX25FJJVL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,338
Award facts
- Contract value 100% obligated
- $14,338.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Palivizumab 100mg/mL. This firm fixed-price delivery order, valued at $14,338.44, represents a non-set-aside competitive award and is scheduled for completion by October 10, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company serves critical healthcare systems including the Defense Health Agency and U.S. Coast Guard, supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Palivizumab, a respiratory syncytial virus immunoglobulin, represents a specialized pharmaceutical product consistent with the company's role as a primary vendor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DX25FJJVL?
SPE2DX25FJJVL was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 19, 2025.
How much is contract SPE2DX25FJJVL worth?
The government has obligated $14,338 on SPE2DX25FJJVL.
Is contract SPE2DX25FJJVL an order under another contract?
Yes. SPE2DX25FJJVL is a delivery order under SPE2DX15D7062, an indefinite delivery contract.
Was contract SPE2DX25FJJVL competed?
The extent of competition for SPE2DX25FJJVL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award